Baxy Pharmaceuticals Private Limited
About Baxy Pharmaceuticals Private Limited
Data last updated:
Baxy Pharmaceuticals Private Limited is a private limited company based in Karan Nagar, Jammu And Kashmir, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 07 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U74999JK2018PTC010482.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Muskan Firdous Raina and Javid Jehangir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Baxy House Bazar Batamallo Near Water Tank Police Station Batamallo, Karan Nagar, Jammu and Kashmir, India – 190010.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.65 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹54,063 (net margin 3.1%) and EBITDA of ₹63,076 (EBITDA margin 3.6%).
Company details
Contact details
Baxy Pharmaceuticals Private Limited's registered office is in Karan Nagar, Jammu And Kashmir. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressBaxy House Bazar Batamallo Near Water Tank Police Station Batamallo, Karan Nagar, Jammu and Kashmir, India – 190010
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Baxy Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Baxy Pharmaceuticals Private Limited
FY 2025 filings availableBaxy Pharmaceuticals Private Limited reported revenue of ₹17.65 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹63,076 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54,063 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baxy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Baxy Pharmaceuticals Private Limited
Baxy Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muskan Firdous Raina | Director | 07 Jun 2018 | 8 Years 4 Months | Current |
| Javid Jehangir Also directs: Oaktech Biopharma Private Limited | Director | 07 Jun 2018 | 8 Years 4 Months | Current |
| Shubeena Muzaffar | Director | 20 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Baxy Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vipanil Pharmaceuticals Private Limited | ₹17.68 Lakh (FY 2025) | 4.0% | Delhi, India | |||
| Mevon Pharmaceuticals Private Limited | ₹17.66 Lakh (FY 2024) | 57.0% | Patna, Bihar, India | |||
| Pacur Pharmaceuticals Private Limited | ₹17.66 Lakh (FY 2024) | 44.0% | Chhindwara, Madhya Pradesh, India | |||
| Carmaluxe Pharmaceuticals Private Limited | ₹17.65 Lakh (FY 2025) | -37.0% | Pune, Maharashtra, India | |||
| Ranek Pharmaceuticals Private Limited | ₹17.65 Lakh (FY 2024) | 169.0% | Guwahati, Assam, India | |||
| Baxy Pharmaceuticals Private Limitedthis company | ₹17.65 Lakh (FY 2025) | ₹54,063 | 3.1% | -4.0% | Karan Nagar, Jammu And Kashmir, India | |
| Viams Pharmaceuticals Private Limited | ₹17.63 Lakh (FY 2025) | -8.0% | Delhi, India | |||
| Mayuvachi Pharmaceuticals Private Limited | ₹17.6 Lakh (FY 2025) | 24.0% | Gwalior, Madhya Pradesh, India | |||
| Medcharm Pharmaceuticals Private Limited | ₹17.6 Lakh (FY 2025) | -26.0% | Baddi, Himachal Pradesh, India | |||
| P-Ferd Pharmaceuticals Private Limited | ₹17.6 Lakh (FY 2025) | 59.0% | Pune, Maharashtra, India | |||
| Victomed Pharmaceuticals Private Limited | ₹17.58 Lakh (FY 2025) | -2.0% | Theni, Tamil Nadu, India |
To see the full peer comparison of Baxy Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Baxy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baxy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Baxy Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Baxy Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Muskan Firdous Raina ceased to be Director on 20 Nov 2025.
Frequently asked questions
Baxy Pharmaceuticals is an active private limited company based in Karan Nagar, Jammu And Kashmir, India. The company works in other services, within the business services industry. It was incorporated on 07 June 2018 (8+ years old) and is registered under CIN U74999JK2018PTC010482.
Baxy Pharmaceuticals has 3 current directors:
- Muskan Firdous Raina - Director
- Javid Jehangir - Director
- Shubeena Muzaffar - Director
The latest financial statements of Baxy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Baxy Pharmaceuticals is U74999JK2018PTC010482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baxy Pharmaceuticals was incorporated on 07 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Baxy Pharmaceuticals by revenue are Vipanil Pharmaceuticals Private Limited, Mevon Pharmaceuticals Private Limited, Pacur Pharmaceuticals Private Limited, Carmaluxe Pharmaceuticals Private Limited, Ranek Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Muskan Firdous Raina ceased to be Director on 20 Nov 2025. Shubeena Muzaffar was appointed as Director on 20 Nov 2025. Javid Jehangir was appointed as Director on 07 Jun 2018. Baxy Pharmaceuticals has 4 board changes on record in total.
The registered office of Baxy Pharmaceuticals is at Baxy House Bazar Batamallo Near Water Tank Police Station Batamallo, Karan Nagar, Jammu and Kashmir, India – 190010.
Baxy Pharmaceuticals operates in the business services industry, in the other services segment.
Baxy Pharmaceuticals can be reached at its registered office: Baxy House Bazar Batamallo Near Water Tank Police Station Batamallo, Karan Nagar, Jammu and Kashmir, India – 190010.
Baxy Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jammu.